Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Philip J, Sherratt"'
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 379:166-174
During drug development, potential safety issues can occur at any time. Understanding the cause of a toxicity can help with deciding on how to advance the drug development program. Chemoproteomics provides a way to help understand the cause of a toxi
Autor:
Lila Ramaiah, Douglas A. Keller, Michael Merz, David Brott, Silvia Lentini, Lucas Westcott‐Baker, Paul B. Watkins, Shashi K. Ramaiah, David L. Bourdet, Ann Marie Stanley, Rachel J. Church, Sharin E. Roth, Ajit Dash, Philip J. Sherratt, Mark I. Avigan, John Marcinak
Publikováno v:
Clinical Pharmacology and Therapeutics
The diagnosis and management of drug-induced liver injury (DILI) remains a challenge in clinical trials in drug development. The qualification of emerging biomarkers capable of predicting DILI soon after the initiation of treatment, differentiating D
Autor:
Paul, Nioi, Ingrid D R, Pardo, Philip J, Sherratt, Mark R, Fielden, Jeremy, Gollub, Alex, Nie, Ronald D, Snyder
Publikováno v:
Chemico-Biological Interactions. 176:252-260
Carcinogenicity of chemicals can currently only be evaluated in 2-year rodent bioassays. Therefore, the development of early biomarkers for carcinogenesis would result in substantial savings in time and expense. The current study investigates whether
Publikováno v:
Molecular and Cellular Biology. 25:10895-10906
Nrf2 is a transcription factor critical for the maintenance of cellular redox homeostasis. We have previously found that Nrf2 is a labile protein, and its activation in cells under stress involves mechanisms leading to its stabilization. As a modular
Publikováno v:
Journal of Biological Chemistry. 280:32485-32492
Nrf2 regulates the expression of genes encoding antioxidant proteins involved in cellular redox homeostasis. Previous studies have suggested that activation of Nrf2 is mediated by mechanisms promoting its dissociation from Keap1, a cytosolic represso
Publikováno v:
Annual Review of Pharmacology and Toxicology. 43:233-260
The expression of genes encoding antioxidative and Phase II detoxification enzymes is induced in cells exposed to electrophilic compounds and phenolic antioxidants. Induction of these enzymes is regulated at the transcriptional level and is mediated
Publikováno v:
Journal of Biological Chemistry. 278:4536-4541
Nrf2 (NF-E2-related factor 2) is a central transcription factor involved in the transcriptional activation of many genes encoding phase II drug-metabolizing enzymes via the antioxidant response element. Nrf2 has previously been found to undergo nucle
Publikováno v:
Methods in enzymology. 378
Publisher Summary The antioxidant response element (ARE) is a cis-acting enhancer that coordinates the induction of a battery of genes in response to oxidative stress and electrophilic compounds. These genes contain the consensus ARE sequence within
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9257c9db85c91496f2d6660a2bbe0349
https://doi.org/10.1016/s0076-6879(04)78022-2
https://doi.org/10.1016/s0076-6879(04)78022-2
Autor:
Vincent P. Kelly, Tania O'Connor, Elizabeth M. Ellis, Linda S. Ireland, Cara M. Slattery, Philip J. Sherratt, Dorothy H. Crouch, Christophe Cavin, Benoît Schilter, Andrea Gallina, John D. Hayes
Publikováno v:
ACS Symposium Series ISBN: 9780841238466
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6b7b0e0dcbfa1de0d7568e5441774d8
https://doi.org/10.1021/bk-2003-0865.ch011
https://doi.org/10.1021/bk-2003-0865.ch011